Viewing Study NCT06307457


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2025-12-25 @ 4:35 PM
Study NCT ID: NCT06307457
Status: COMPLETED
Last Update Posted: 2025-06-29
First Post: 2024-03-05
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-03-06
Start Date Type: ACTUAL
Primary Completion Date: 2024-04-19
Primary Completion Date Type: ACTUAL
Completion Date: 2024-04-19
Completion Date Type: ACTUAL
First Submit Date: 2024-03-05
First Submit QC Date: None
Study First Post Date: 2024-03-12
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-04-10
Results First Submit QC Date: None
Results First Post Date: 2025-06-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-06-09
Last Update Post Date: 2025-06-29
Last Update Post Date Type: ACTUAL